Skip to main content
. 2019 Jul 4;19:149. doi: 10.1186/s12883-019-1379-2

Table 1.

Overview of the questionnaires, neurological tests, and kinetic and neurophysiological measurements at the various points in time of the SCA3-tDCS study

T0 baseline T0 after tDCS T1 day 12 T2 3 months T3 6 months T4 12 months
Questionnaires
 EQ-5D-5L X X X X X
 PHQ-9 X X X X X
 POMS 32-item X X X X X
 iMCQ X X
 IPAQ parts 1 and 4 X X X
 FARS part II (ADL) X X X X X
Neurological examination
 CCAS scale X X X X X
 SARA X X X X X X
 8MWT X X X X X X
 9HPT X X X X X X
 PATA repetition X X X X X X
 INAS X X X X X
Measurements
 TMS X X
 Delay EBC X X
 Static posturography X X X

EQ-5D-5L EuroQol 5-Dimension 5-Level, PHQ-9 Patient Health Questionnaire-9, POMS Profile of Mood States, iMCQ Institute for Medical Technology Assessment (iMTA) Medical Consumption Questionnaire, IPAQ International Physical Activity Questionnaire; FARS Friedreich Ataxia Rating Scale, ADL Activities of Daily Living, CCAS Cerebellar Cognitive Affective Syndrome, SARA Scale for the Assessment and Rating of Ataxia, 8MWT 8 m walk test, 9HPT 9-hole peg test, INAS Inventory of Non-Ataxia Signs, TMS Transcranial magnetic stimulation, EBC Eyeblink conditioning